Elmiron Eye Lawsuit News

Former Elmiron Patients Should Consider Adding Acupuncture To A Holistic Bladder Pain Treatment Regimen

Elmiron eye damage is forcing millions of people to seek holistic medical treatment for interstitial cystitis

Tuesday, October 12, 2021 - New and innovative ways to treat the millions of women who suffer from interstitial cystitis (IC) are coming forth each week as Elmiron, the drug that once enjoyed a bladder pain relief monopoly, comes under legal pressure. Individuals have filed Elmiron eye problem lawsuits alleging that taking the drug caused them to lose their ability to see at night. The newest form of holistic treatment for chronic bladder pain is a multi-faceted approach that includes acupuncture, an ancient Asian pain treatment to be included as part of a total body approach to alleviating bladder pain. Yahoo News reported on a Dr. Yang Ahn of the Ahn Clinic as one who uses acupuncture to treat interstitial cystitis of chronic bladder pain. IC causes women to feel that they must use the toilet constantly during the day and night. Having to urinate frequently makes it impossible to enjoy a normal life. Dr. Ang tells the patient that IC is the irritation of the lining of the bladder. Dr. Ang uses acupuncture to "calm down an overactive immune system," which, in his words, is responsible for irritating the bladder. Acupuncture treatments may be combined with super-concentrated Aloe Vera capsules and improving the diet. It is also advisable to stop eating spicy foods and drinking alcohol and coffee and eat more non-acidic fruits and vegetables.

For more than 25 years doctors recommended that their patients that suffered from bladder pain take Elmiron, (pentosan polysulfate sodium, or "PPS") regularly and permanently. Elmiron was approved in 1996 and since then no other company has offered competition in the bladder pain medicine space. Janssen Pharmaceuticals, a subsidiary of the Johnson & Johnson family of companies is the only one to sell the IC treatment. Hundreds of women that have been diagnosed with pigmentary maculopathy allege in Elmiron eye lawsuit that taking the drug regularly caused them to lose a large portion of their visions. People with macular degeneration or pigmentary maculopathy develop spots on the retina, a surface in the back of the eye that is responsible for clear vision. Women with the condition have difficulty reading and also difficulty seeing at night.

Doctors that are aware of the studies that link taking Elmiron with developing macular degeneration need to inform their patients of the risk that taking the drug could permanently and irreversibly ruin their eyesight. Studies from prestigious scientific think tanks not only link taking Elmiron with having a one out of four chance of losing their vision but also of the fact that their Elmiron vision loss will continue to progress even if they stop taking the drug down the road. To make matters worse, more and more experts believe, and lawsuits have picked up on the fact that taking Elmiron produces a placebo effect and in reality is ineffective. To cover for this, Janssen tells their readers that they have to take Elmiron for three months or more before pain relief can be expected. Doctors should shun prescribing Elmiron given the facts, and recommend alternatives that could help their patients.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.